Integrative Transcriptomic and Genetic Analyses Identify CDC20 as a Potential Biomarker Associated with Cell Cycle and Immune-Inflammatory Processes in Psoriasis.

Yang L, Mo W, Wang G, Wu X

Open source

DOI
10.2147/ccid.s636697
Published
2026
Container
Clinical, cosmetic and investigational dermatology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ccid.s636697,
  title = {Integrative Transcriptomic and Genetic Analyses Identify CDC20 as a Potential Biomarker Associated with Cell Cycle and Immune-Inflammatory Processes in Psoriasis.},
  author = {Yang L and Mo W and Wang G and Wu X},
  year = {2026},
  journal = {Clinical, cosmetic and investigational dermatology},
  doi = {10.2147/ccid.s636697},
  url = {https://doi.org/10.2147/ccid.s636697}
}

RIS

TY  - JOUR
TI  - Integrative Transcriptomic and Genetic Analyses Identify CDC20 as a Potential Biomarker Associated with Cell Cycle and Immune-Inflammatory Processes in Psoriasis.
AU  - Yang L
AU  - Mo W
AU  - Wang G
AU  - Wu X
PY  - 2026
JO  - Clinical, cosmetic and investigational dermatology
DO  - 10.2147/ccid.s636697
UR  - https://doi.org/10.2147/ccid.s636697
ER  - 

APA

L, Y., W, M., G, W., & X, W. (2026). Integrative Transcriptomic and Genetic Analyses Identify CDC20 as a Potential Biomarker Associated with Cell Cycle and Immune-Inflammatory Processes in Psoriasis.. Clinical, cosmetic and investigational dermatology. https://doi.org/10.2147/ccid.s636697

Source records